Self-calibrating gradient dilution in a constituent assay and gradient dilution apparatus performed in a thin film sample
A method and apparatus for measuring antibody titers in a thin film sample in an automated system which does not require multiple dilutions. The system provides a simple method for creating an in-situ dilution within a sample analysis chamber without the use of any precision fluid-handling components, and further, to use the same principles to provide a wide range of sample dilutions within the chamber so as to obviate the need for additional dilution steps when dealing with samples possibly containing wide ranges of analyte concentrations.
1. A method for determining the relative dilution of a solution containing a ligand which is directed against a target analyte, and a liquid sample containing the target analyte to be analyzed, which target analyte sample is miscible with said ligand solution, at least one of said solution and said sample containing a detectable sensible marker, said method comprising the steps of:
a) placing an effective amount of said solution in one area of a planar reaction chamber having a thin through thickness dimension;
b) placing an effective amount of said target analyte sample in an adjacent area of said planar chamber;
c) allowing or causing said solution and said sample to admix with each other until an admixture gradient is created in a solution-sample mixture in said chamber;
d) electronically imaging or scanning said admixture gradient in said chamber between a first location containing an undiluted amount of said solution and a second location containing an undiluted amount of said target analyte sample; and
e) calculating a relative concentration or dilution of each of said solution and said sample by measuring the concentration of said detectable sensible marker in said mixture in said imaged area.
2. The method of claim 1 wherein said solution contains a detectable sensible marker.
3. The method of claim 1 wherein said liquid sample contains a detectable sensible marker.
4. The method of claim 1 wherein said allowing or causing admixing step is performed by pumping said solution and said sample in said chamber.
5. The method of claim 1 wherein said allowing or causing admixing step is performed by baffling flow of at least one of said solution and liquid sample into said chamber.
6. The method of claim 5 wherein said chamber is less than 200 μm in thickness.
7. The method of claim 1 wherein said chamber is less than 1 mm in thickness.
8. The method of claim 1 wherein the risk of false negatives due to a prozone effect is removed by expanding the range of the immunoassay to assure more accurate immunoassay results.
9. The method of claim 1 wherein a standard calibration curve is performed in the same chamber as the sample analysis.
10. A method for determining the relative dilution of a solution containing a ligand which is directed against a target analyte, and a liquid sample containing the target analyte to be analyzed, which target analyte sample is miscible with said ligand solution, at least one of said solution and said sample containing a detectable sensible marker, said method comprising the steps of:
a) placing an effective amount of said solution in one area of a planar reaction chamber having a thin through thickness dimension;
b) placing an effective amount of said target analyte sample in an adjacent area of said planar chamber;
c) allowing or causing said solution and said sample to admix with each other until an admixture gradient is created in a solution-sample mixture in said chamber;
d) electronically imaging or scanning said admixture gradient in said chamber between a first location containing an undiluted amount of said solution and a second location containing an undiluted amount of said target analyte sample; and
calculating a relative concentration or dilution of each of said solution and said sample by measuring the concentration of said detectable sensible marker in said mixture in said imaged area;
wherein both said solution and said liquid sample contain detectable sensible markers and wherein said detectable sensible markers produce different detectable signals.
11. A method for determining the relative dilution of a solution containing a ligand which is directed against a target analyte, and a liquid sample containing the target analyte to be analyzed, which target analyte sample is miscible with said ligand solution, at least one of said solution and said sample containing a detectable sensible marker, said method comprising the steps of:
a) placing an effective amount of said solution in one area of a planar reaction chamber having a thin through thickness dimension;
b) placing an effective amount of said target analyte sample in an adjacent area of said planar chamber;
c) allowing or causing said solution and said sample to admix with each other until an admixture gradient is created in a solution-sample mixture in said chamber;
d) electronically imaging or scanning said admixture gradient in said chamber between a first location containing an undiluted amount of said solution and a second location containing an undiluted amount of said target analyte sample; and
e) calculating a relative concentration or dilution of each of said solution and said sample by measuring the concentration of said detectable sensible marker in said mixture in said imaged area; and
f) adding a viscosity increasing agent which can form at least a partial gel in said sample so as to allow the sample to be incubated for an extended period of time following said admixing step in order for a delayed reaction to proceed.
12. The method of claim 11 wherein a prozone effect is avoided.